NCT03518801View on ClinicalTrials.gov

Cannabidiol and Prolonged Exposure

PHASE2CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
PTSD
Interventions
BEHAVIORAL

Prolonged Exposure

psychotherapy

DRUG

Cannabidiol

active medication

DRUG

placebo

non-active medication

Trial Locations (1)

92161-0002

VA San Diego Healthcare System, San Diego, CA, San Diego

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

lead

VA Office of Research and Development

FED

NCT03518801 - Cannabidiol and Prolonged Exposure | Biotech Hunter | Biotech Hunter